Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Intersect ENT Announces FDA Submission To Seek Expanded Indication Of PROPEL Mini Steroid Releasing Implant To Treat Patients With Frontal Sinus Disease

 

Intersect ENT Announces FDA Submission To Seek Expanded Indication Of PROPEL Mini Steroid Releasing Implant To Treat Patients With Frontal Sinus Disease

2015-09-30 08:48:02| drugdiscoveryonline News Articles

Intersect ENT, Inc., a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, recently announced that the company has submitted a supplemental premarket approval (PMA-s) submission to the U.S

Tags: mini expanded disease patients

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

01.11 Boeing makes 38% pay rise offer in bid to end strike 01.11 The house paints that promise much more than colour 01.11 Eastern North Pacific Tropical Weather Outlook 01.11 Atlantic Tropical Weather Outlook 01.11 Technology adoption: What's on the ag tech horizon for 2025 01.11 Technology adoption: What's on the ag tech horizon for 2025 01.11 How Japan's youngest CEO transformed Hello Kitty 31.10 Unicharm to Expand in Africa More »